Core Scientific Inc 2026年季度报告

(Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September30, 2025OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromtoCommission file number 001-40046 Core Scientific, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 838 Walker RoadSuite 21-2105Dover, Delaware(Address of Principal Executive Offices)19904(Zip Code)(512) 402-5233(Registrant's telephone number, including area code) Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filingrequirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 ofRegulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Table of Contents Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. Large accelerated filer☒Accelerated filer☐Emerging growth companyNon-accelerated filer☐Smaller reporting company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the SecuritiesExchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes☒No☐ As of October20, 2025, 310,061,300 shares of Common Stock, par value $0.00001, were outstanding. EXPLANATORY NOTE Core Scientific, Inc. (the “Company”) is amending its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2025, asoriginally filed with the Securities and Exchange Commission (the "SEC") on October 24, 2025 (hereinafter referred to as the “Original Filing” and, asamended, the “Amendment”), and is separately amending its Annual Report on Form 10-K for the year ended December 31, 2024 and its QuarterlyReports on Form 10-Q for the quarterly periods ended March 31, 2025 and June 30, 2025 (such amended reports, together with this Amendment, the“Amended Reports”), in each case to correct identified errors in its previously issued consolidated financial statements as further described below as wellas in Note 3 – Restatement of Previously Issued Financial Statements, in Part I. Item 1 – Financial Statements, to the restated condensed consolidatedfinancial statements included in this Amendment. During the preparation of the consolidated financial statements for the year ended December 31, 2025, the Company determined that property, plantand equipment was overstated as a result of the improper continued capitalization of carrying values of assets committed to demolition in connection withthe conversion of certain facilities from digital asset mining operations to high-performance computing colocation infrastructure, which impacted theCompany’s previously issued consolidated financial statements as of and for the year ended December 31, 2024, as well as the condensed consolidatedfinancial statements as of and for the three and six months ended June 30, 2024, the three and nine months ended September 30, 2024, the three monthsended March 31, 2025, the three and six months ended June 30, 2025, and the three and nine months ended September 30, 2025 (the “Non-ReliancePeriods”). Specifically, the carrying values of assets committed to demolition were improperly capitalized rather than being written down to fair valuethrough the recognition of impairment charges in the periods in which the commitment to demolish was made. The Company assessed the materiality of the errors, individually and in the aggregate, and concluded that the errors were material to the previouslyissued financial statements and such previously issued financial statements should no longer be relied upon. As a result, the Company is restating itspreviously issued consolidated financial statements for the Non-Reliance Periods. As all material restatement informati